$PROC News

Last published 1y ago

1y agoPROCProcaps Group Receives Delisting Notice From NasdaqGlobeNewswireMIAMI and BARRANQUILLA, Columbia, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ:PROC) ("Procaps" or the "Company"), a leading integrated LatAm healthcare and pharmaceutical services company, today
1y agoPROCProcaps Group Receives Additional Delinquency LetterGlobeNewswireMIAMI and BARRANQUILLA, Columbia, Jan. 03, 2025 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ:PROC) ("Procaps" or the "Company"), a leading integrated LatAm healthcare and pharmaceutical services company, today
1y agoPROCProcaps Group Announces Key Shareholder and Board Decisions, Committee Restructuring, and Leadership UpdatesGlobeNewswireMIAMI and BARRANQUILLA, Colombia, Dec. 20, 2024 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ:PROC) ("Procaps" or the "Company"), a leading integrated LatAm healthcare and pharmaceutical services company, today
1y agoPROCProcaps Group Announces Financing, Shareholders Agreement and Board UpdatesGlobeNewswireMIAMI and BARRANQUILLA, Colombia , Dec. 03, 2024 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ:PROC) ("Procaps" or the "Company"), a leading integrated LatAm healthcare and pharmaceutical services company, today
1y agoPROCProcaps Receives Nasdaq Listing Determination; To Request Hearing and Further Stay Pending HearingGlobeNewswireMIAMI and BARRANQUILLA, Colombia, Nov. 15, 2024 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ:PROC) ("Procaps" or the "Company"), announced today that, on November 13, 2024, the Company received formal notice from
2y agoPROCProcaps Issues Shareholder Letter UpdateGlobeNewswireMIAMI and BARRANQUILLA, Colombia, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ:PROC) ("Procaps" or the "Company"), a leading integrated LatAm healthcare and pharmaceutical services, today issued the
2y agoPROCProcaps Issues Shareholder Letter UpdateGlobeNewswireMIAMI and BARRANQUILLA, Colombia, Sept. 18, 2024 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ:PROC) ("Procaps" or the "Company"), a leading integrated LatAm healthcare and pharmaceutical services, today issued the
2y agoPROCProcaps Issues Shareholder LetterGlobeNewswireMIAMI and BARRANQUILLA, Colombia, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ:PROC) ("Procaps" or the "Company"), a leading integrated LatAm healthcare and pharmaceutical conglomerate, today issued
2y agoPROCProcaps Group Announces New ChairmanBusiness WireRuben Minski decides to step down as Executive Chairman and José Minski is appointed as new Chairman of the Board Procaps Group, S.A. (NASDAQ:PROC) ("Procaps" or the "Company"), a leading integrated LatAm healthcare
2y agoPROCProcaps Group Receives Nasdaq Notice Related to Late Filing of its Form 20-FBusiness WireProcaps Group (NASDAQ:PROC) ("Procaps" or the "Company"), a leading integrated LatAm healthcare and pharmaceutical services company, today announced that it has received a letter from the Nasdaq Stock Market, dated May
2y agoPROCProcaps Group Delays Filing of Annual Report on Form 20-FBusiness WireProcaps Group (NASDAQ:PROC) ("Procaps" or the "Company"), a leading integrated LatAm healthcare and pharmaceutical services company, today announced that it has determined it is unable to file its Annual Report on Form
2y agoPROCProcaps Group Delays Filing of Annual Report on Form 20-FBusiness WireProcaps Group (NASDAQ:PROC) ("Procaps" or the "Company"), a leading integrated LatAm healthcare and pharmaceutical services company, today announced that it has determined it is unable to file its Annual Report on Form
2y agoPROCProcaps Announces Formation of Strategic Committee to Explore Value Creation AlternativesBusiness WireProcaps Group (NASDAQ:PROC) ("Procaps" or the "Company"), a leading integrated LatAm healthcare and pharmaceutical services company, today announced that it is conducting a process to explore strategic alternatives to
2y agoPROCProcaps Issues Shareholder Letter from New CEOBusiness WireProcaps Group (NASDAQ:PROC) ("Procaps" or the "Company"), a leading integrated LatAm healthcare and pharmaceutical conglomerate, today issued a letter to shareholders from Jose Vieira, CEO of Procaps. Dear
2y agoPROCProcaps Group – Notice to ShareholdersBusiness WireDear Shareholders, We became aware on Saturday, January 13, 2024, that the online voting instructions related to the upcoming General Meeting of Shareholders of the Company scheduled for January 22, 2024, were
2y agoPROCProcaps Group Reports Third Quarter 2023 ResultsBusiness WireNet Revenues Increased 5% in 9M23 Year-over-Year on a Constant Currency Basis, Driven by 13% RX Growth Procaps Group, S.A. (NASDAQ:PROC) ("Procaps" or the "Company"), a leading integrated international healthcare and
2y agoPROCStatement from the Board of Directors of Procaps GroupBusiness WireProcaps Group (NASDAQ:PROC) ("Procaps"). Having completed the last ordinary meeting of 2023 on December 19th in which Ruben Minski acted as CEO of the Procaps Group for the last time, and taking into account
2y agoPROCProcaps Group and Genomma Lab Announce a Strategic Agreement to Manufacture and Market Softgel Products in Latin AmericaPR NewswireProcaps Group (NASDAQ: PROC) ("Procaps"), a leading integrated international healthcare and pharmaceutical services company, and Genomma Lab...
2y agoBMV:LABB PROCProcaps Group and Genomma Lab Announce a Strategic Agreement to Manufacture and Market Softgel Products in Latin AmericaBusiness WireAgreement Combines Procaps Oral Delivery System Technology and Manufacturing with Genomma's Strategic Marketing and Distribution Footprint Procaps Group (NASDAQ:PROC) ("Procaps"), a leading integrated international
2y agoPROCProcaps Group Announces Appointment of Jose Antonio Vieira as Chief Executive Officer Starting 2024Business WireProcaps Group (NASDAQ:PROC) ("Procaps"), a leading integrated LatAm healthcare and pharmaceutical conglomerate, announced today a strategic leadership transition as Ruben Minski, founder and CEO of Procaps prepares to
2y agoPROCProcaps Group Update on Third Quarter ResultsBusiness WireProcaps Group (NASDAQ:PROC) ("Procaps"), a leading integrated LatAm healthcare and pharmaceutical services company, today announced that it is postponing the previously-announced earnings conference call (currently
3y agoPROCProcaps Group to Report Third Quarter and Nine Months 2023 Results on Tuesday November 14, 2023Business WireCompany to Host Conference Call on Thursday November 16, 2023 at 10:30 a.m. Eastern Time Procaps Group (NASDAQ:PROC) ("Procaps"), a leading integrated LatAm healthcare and pharmaceutical services company, announced it
3y agoPROCProcaps Group Wins First Place in Ranking of Innovative Companies in the Pharma Sector in ColombiaBusiness WireProcaps Ranked First Among Companies in the Pharmaceutical Segment in Colombia for the 5th Consecutive Year Procaps Group (NASDAQ:PROC) ("Procaps"), a leading integrated LatAm healthcare and pharmaceutical
3y agoPROCProcaps Appoints Sandra Sánchez y Oldenhage to Board of DirectorsBusiness WireExperienced Pharma Professional Brings Wealth of International Industry and Governance Experience to Board Procaps Group (NASDAQ:PROC) ("Procaps" or the "Company"), a leading integrated LatAm healthcare and
3y agoPROCProcaps Group to Participate at CPHI Barcelona 2023Business WireProcaps Group (NASDAQ:PROC) ("Procaps"), a leading integrated LatAm healthcare and pharmaceutical conglomerate, announced today that it will participate at the CPHI Barcelona 2023, that will take place from October 24th
3y agoPROCProcaps Group to Host Webinar on Colombian Pharma MarketBusiness WireThe Webinar will occur on Tuesday, October 10, 2023 at 10:00 a.m. Eastern Time Procaps Group (NASDAQ:PROC) ("Procaps"), a leading integrated LatAm healthcare and pharmaceutical services company, announced that it will
3y agoPROCProcaps Group to Participate at BTG 2023 LatAm CEO Conference and Roth 2023 Healthcare Opportunities Conference in OctoberBusiness WireProcaps Group, S.A. (NASDAQ:PROC) ("Procaps" or the "Company"), a leading integrated LatAm healthcare and pharmaceutical services company, announced today that members of its executive leadership team will participate
3y agoPROCProcaps Group Announces the Expansion of its Oncology PortfolioBusiness WireThe Agreement Substantially Increases Procaps' Participation in the Oncology Market in the LatAm Region Procaps Group, S.A. (NASDAQ:PROC) ("Procaps" or the "Company"), a leading integrated LatAm healthcare and
3y agoPROCProcaps Group S.A. (PROC) Q2 2023 Earnings Call TranscriptEarnings Call Transcripts
3y agoPROCProcaps Group Reports Second Quarter 2023 ResultsBusiness WireNet Revenues Increased 7% in 1H23 Year-over-Year, on a Constant Currency Basis, Signaling Positive Performance of Rx Products Procaps Group, S.A. (NASDAQ:PROC) ("Procaps" or the "Company"), a leading integrated
3y agoPROCProcaps Group to Report Second Quarter and First Half 2023 Results and Host Conference Call on TuesdayBusiness WireProcaps Group (NASDAQ:PROC) ("Procaps"), a leading integrated LatAm healthcare and pharmaceutical services company, announced that it will report its results for the second quarter and six months ended June 30, 2023,
3y agoPROCProcaps Group Publishes White Paper on Innovative Gummy TechnologyBusiness WireIntroduces New High Temperature Gummy Technology Platform that Solves Formulation and Distribution Challenges Procaps Group, S.A. (NASDAQ:PROC) ("Procaps" or the "Company"), a leading integrated LatAm healthcare and
3y agoPROCProcaps Group Reports First Quarter 2023 ResultsGlobeNewswireMIAMI and BARRANQUILLA, Colombia, June 05, 2023 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ:PROC) ("Procaps"), a leading integrated international healthcare and pharmaceutical services company, today announced its
3y agoPROCProcaps Group Reports Fourth Quarter and Full Year 2022 ResultsBusiness WireConstant Currency Net Revenues Increased 7% Year-over-Year in 2022, With Strong Demand of RX and Softgel Portfolios, Offset by Clinical Specialty Covid Portfolio Preliminary Results for 1Q23 Show a Significant Rebound
3y agoPROCFinancial Results and Business Update Conference Call to be Held May 2023 in Conjunction with 20-F FilingGlobeNewswireMIAMI and BARRANQUILLA, Colombia, May 01, 2023 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ:PROC) ("Procaps" or the "Company"), a leading integrated LatAm healthcare and pharmaceutical conglomerate, announced today
3y agoPROCProcaps Issues Shareholder Letter and Provides Preliminary Fiscal Year 2022 Financial Results and 2023 GuidanceGlobeNewswireReports Preliminary Financial Estimates for Net Revenue and Adjusted EBITDA for Full Year 2022 Realigns Board of Directors to Focus on Profitable Growth Announces $5M+ Share Repurchase Program Commences $15MM Cost
3y agoPROCProcaps Announces Key Changes to the Board of DirectorsGlobeNewswireMIAMI and BARRANQUILLA, Colombia, Jan. 19, 2023 (GLOBE NEWSWIRE) -- Procaps Group (NASDAQ:PROC) ("Procaps" or the "Company"), a leading integrated LatAm healthcare and pharmaceutical conglomerate, announced the
3y agoPROCProcaps Group Announces Termination of Acquisition Agreement with Grupo SomarGlobeNewswireMIAMI and BARRANQUILLA, Colombia, Jan. 03, 2023 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ:PROC) ("Procaps" or the "Company"), a leading integrated LatAm healthcare and pharmaceutical conglomerate, today
3y agoPROCProcaps to Present at 2023 Annual J.P. Morgan Healthcare ConferenceGlobeNewswireMIAMI and BARRANQUILLA, Colombia, Dec. 29, 2022 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ:PROC) ("Procaps" or the "Company"), a leading integrated LatAm healthcare and pharmaceutical conglomerate, today announced
3y agoPROCUpdate on Proposed Acquisition of Grupo SomarGlobeNewswireMIAMI and BARRANQUILLA, Colo., Dec. 22, 2022 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ:PROC) ("Procaps" or the "Company"), a leading integrated LatAm healthcare and pharmaceutical conglomerate, announces an
3y agoPROCProcaps Group Reports Third Quarter and Nine Months 2022 ResultsGlobeNewswireMIAMI and BARRANQUILLA, Colombia, Nov. 14, 2022 (GLOBE NEWSWIRE) -- Procaps Group S.A. (NASDAQ:PROC) ("Procaps"), a leading integrated LatAm healthcare and pharmaceutical conglomerate, today announced its financial
4y agoPROCProcaps Group to Report Third Quarter and Nine Months of 2022 on November 14, 2022GlobeNewswireMIAMI and BARRANQUILLA, Colombia, Nov. 08, 2022 (GLOBE NEWSWIRE) -- Procaps Group (NASDAQ:PROC) ("Procaps"), a leading integrated LatAm healthcare and pharmaceutical conglomerate, announced that it expects to report
4y agoPROCProcaps Announces ESG Commitments and Initiatives with Inaugural ReportGlobeNewswireMIAMI and BARRANQUILLA, Colombia, Oct. 11, 2022 (GLOBE NEWSWIRE) -- Procaps Group (NASDAQ:PROC) ("Procaps"), a leading integrated LatAm healthcare and pharmaceutical conglomerate, today announced the completion of its
4y agoPROCProcaps Group to Participate in the BTG Pactual LatAm CEO ConferenceGlobeNewswireMIAMI and BARRANQUILLA, Colombia, Oct. 05, 2022 (GLOBE NEWSWIRE) -- Procaps Group (NASDAQ:PROC) ("Procaps"), a leading integrated LatAm healthcare and pharmaceutical conglomerate, today announced it will participate in the BTG Pactual LatAm CEO Confere
4y agoPROCProcaps Group Reports Second Quarter and First Half 2022 ResultsGlobeNewswireNet Revenues Increased 14% year-over-year in the Second Quarter, with Adjusted EBITDA Margin of 24%Constant currency Net Revenues Increased by 18% year-over-year in the First Half, signaling a strong demand across our businesses MIAMI and BARRANQUILLA
4y agoPROCProcaps Group Reports Preliminary First Quarter 2022 ResultsGlobeNewswireMIAMI and BARRANQUILLA, Colombia, June 02, 2022 (GLOBE NEWSWIRE) -- Procaps Group S.A. (NASDAQ:PROC) ("Procaps"), a leading integrated LatAm healthcare and pharmaceutical conglomerate, today announced its preliminary financial results for the quarter e
4y agoPROCProcaps Group to Acquire Grupo Somar (including Química y Farmacia, Gelcaps and related entities) from Advent International, gaining an important presence in Mexico, the Region's Second Largest MarketGlobeNewswireThis acquisition reaffirms Procaps Groups' strategy to become one of the fastest growing pharmaceutical organizations in Latin America With FY2021 Net Revenues of $184 million, Grupo Somar is one of the most relevant independent pharma companies in
4y agoPROC PROCWProcaps Group Reports Fourth Quarter and Fiscal Year 2021 Financial ResultsBusiness WireFiscal Year 2021 Net Revenues Increased 23.6% to $409.7 Million, with Adjusted EBITDA Up 17.8% Year-Over-Year to $99.7 Million Strong Double Digit 2021 Revenue Growth in All Business Units Driven by Market Share Gains and New Product Launches Comp
4y agoPROCProcaps Group Announces Capacity Expansion Plans in the United States with Construction of New Gummy Manufacturing Facility in FloridaBusiness WireNew Funtrition Gummy Manufacturing Facility in Florida Slated to be Fully Operational by Q1 2023 Production Facility to Support Increased U.S. Demand of Advanced Gummy Technologies for the Global Nutraceutical Industry Expansion Plan Expected to D
4y agoPROCProcaps Group Announces Appointment of Melissa Angelini as Investor Relations DirectorBusiness WirePharmaceutical Industry and Investor Relations Veteran to Lead Capital Markets Communications Strategy Procaps Group (NASDAQ:PROC), a leading integrated international healthcare and pharmaceutical company, today announced the appointment of Melissa A